DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Ubiquinol is an investigational drug.
There have been 11 clinical trials for Ubiquinol. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2017.
The most common disease conditions in clinical trials are Syndrome, Heart Failure, and Mitochondrial Diseases. The leading clinical trial sponsors are Beth Israel Deaconess Medical Center, Kaneka Pharma America LLC, and PharmEvo Pvt Ltd.
There are one hundred and one US patents protecting this investigational drug and six hundred and forty-four international patents.
Recent Clinical Trials for Ubiquinol
|Clinical and Biochemical Assessment of the Effect of Topical Use of Coenzyme Q10 Versus Topical Corticosteroid in Management of Symptomatic Oral Lichen Planus: Randomized Controlled Clinical Trial||Cairo University||Phase 1|
|CoQ10 and D-ribose in Patients With Diastolic Heart Failure||University of Kansas Medical Center||Phase 2|
|Neotililty Trial: Effect of Coenzyme Q10 on Semen Parameters in Men With Idiopathic Infertility||PharmEvo Pvt Ltd||Phase 4|
Top disease conditions for Ubiquinol
Top clinical trial sponsors for Ubiquinol
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Ubiquinol||Start Trial||Pre-spray emulsions and powders containing non-polar compounds||Virun, Inc. (Pomona, CA)||Start Trial|
|Ubiquinol||Start Trial||Nutrient combinations for affecting an aging process||BioMarker Pharmaceuticals, Inc. (San Jose, CA)||Start Trial|
|Ubiquinol||Start Trial||Nutritional supplement compositions containing C60-fullerene-phytonutrient-triglyceride complexes for sub-cellular phytonutrient delivery||NextGen Research (Greenville, SC)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Ubiquinol||European Patent Office||3193834||2034-09-18||Start Trial|
|Ubiquinol||World Intellectual Property Organization (WIPO)||2016044805||2034-09-18||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|